SPOTLIGHT: India to convert sites into drug labs

After shuttering three of its oldest vaccine manufacturing facilities for failing to abide by good manufacturing practices, Indian officials have named an expert panel to convert the plants into drug testing laboratories. In addition to safety and efficacy trials, the labs will also be responsible for identifying counterfeit drugs. Drug regulatory officials from WHO and Canada will be brought in to advise the panel in the best way to structure the new labs. Article

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.